Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07012902 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Relationship Between Remimazolam and Etomidate in Induction of General Anesthesia

StatusNot Yet Recruiting
PhaseEarly Phase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated June 10, 2025 (before its estimated June 19, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
In modern anesthesia practice, anesthesiologists often need to choose a combination of multiple drugs according to the specific conditions and surgical needs of patients, which can not only achieve more fine anesthesia management, but also improve perioperative safety and patient comfort. In clinical practice, anesthesiologists will use etomidate combined with a small dose of remimazolam for anesthesia induction to obtain more stable hemodynamics, prevent intraoperative awareness, and relieve anxiety.However, what is the best dose ratio of etomidate combined with remimazolam, the current literature does not give clear indicators.
Trial Details
NCT Number NCT07012902
Lead Sponsor Second Hospital of Shanxi Medical University
Conditions
(from sponsor)		 Induction Anesthesia, Drug Interactions
Enrollment 125 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov